Risk factors for the occurrence and persistence of coronary aneurysms in Kawasaki disease

다국어 초록 (Multilingual Abstract)

Purpose: Prognostic factors of coronary aneurysms in Kawasaki disease have been investigated in many studies. The aim of this study was to identify risk factors associated with early and late coronary artery outcomes in treated patients with Kawasaki disease.
Methods: A total of 392 patients diagnosed with Kawasaki disease from January 2012 to December 2015 in Pusan National University Children’s Hospital were retrospectively selected as subjects of the present study to determine risk factors for coronary aneurysms and persistence of coronary aneurysms after a 1-year follow-up.
Results: Coronary aneurysms were detected in 30 of 392 patients within 1 month after the occurrence of Kawasaki disease. Coronary aneurysms persisted in 5 of 30 patients after a 1-year follow-up. A long duration of fever (adjusted odds ratio [OR], 1.47; 95% confidence interval [CI], 1.06–2.02; P=0.018) and high platelet count (adjusted OR, 1.00; 95% CI, 1.00–1.01; P=0.009) were found to be independent factors to predict the development of coronary aneurysms in the early phase. Initial coronary severity (adjusted OR, 46.0; 95% CI, 2.01–1047.80; P=0.016) and a high white blood cell count (adjusted OR, 1.17; 95% CI, 1.01–1.36; P=0.028) were found to be significant factors for the persistence of late coronary aneurysms in univariate analysis. However, no significant factors were found in multivariate analysis.
Conclusion: These data are from early and late follow-up of coronary aneurysms in our unit. Further studies are needed to determine the mechanisms involved in the disappearance of coronary aneurysms and related factors.

참고문헌 (Reference)

1 허미영, "비정형 가와사키병의 임상 양상" 대한소아청소년과학회 45 (45): 13-382, 2002

2 이영환, "가와사키병" 영남대학교 의과대학 17 (17): 99-107, 2000

3 박지원, "가와사키 환아의 장기 예후에 대한 연구" 대한소아감염학회 22 (22): 164-171, 2015

4 Tewelde H, "The Harada score in the US population of children with Kawasaki disease" 4 : 233-238, 2014

5 Lang B, "Recognizing Kawasaki disease" 6 : 638-643, 2001

6 Kim T, "Predictive risk factors for coronary artery abnormalities in Kawasaki disease" 166 : 421-425, 2007

7 Hye Young Lee, "Predictive factors of resistance to intravenous immunoglobulin and coronary artery lesions in Kawasaki disease" 대한소아청소년과학회 59 (59): 477-482, 2016

8 Jin-Young Baek, "Meta-analysis of factors predicting resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease" 대한소아청소년과학회 59 (59): 80-90, 2016

9 정조원, "Long-Term Outcome of Kawasaki Disease Complicated by a Large Coronary Aneurysm" 대한심장학회 47 (47): 444-445, 2017

10 하기수, "Laboratory Markers in Incomplete Kawasaki Disease according to Coronary Artery Outcome" 대한심장학회 48 (48): 287-295, 2018

11 Burns JC, "Kawasaki disease : a brief history" 106 : E27-, 2000

12 Ha KS, "Incomplete clinical manifestation as a risk factor for coronary artery abnormalities in Kawasaki disease : a meta-analysis" 172 : 343-349, 2013

13 Hirata S, "Incidence rate of recurrent Kawasaki disease and related risk factors : from the results of nationwide surveys of Kawasaki disease in Japan" 90 : 40-44, 2001

14 Kim GB, "Epidemiologic features of Kawasaki disease in South Korea : data from nationwide survey, 2009-2011" 33 : 24-27, 2014

15 Newburger JW, "Diagnosis, treatment, and long-term management of Kawasaki disease : a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association" 114 : 1708-1733, 2004

16 Dajani AS, "Diagnosis and therapy of Kawasaki disease in children" 87 : 1776-1780, 1993

17 Honkanen VE, "Clinical relevance of the risk factors for coronary artery inflammation in Kawasaki disease" 24 : 122-126, 2003

18 Rhim JW, "Changes in Kawasaki disease during 2 decades at a single institution in Daejeon, Korea" 33 : 372-375, 2014

19 Kim JJ, "Assessment of risk factors for Korean children with Kawasaki disease" 33 : 513-520, 2012

20 Lin MT, "Acute and late coronary outcomes in 1073 patients with Kawasaki disease with and without intravenous γ-immunoglobulin therapy" 100 : 542-547, 2015